Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Lee, MD, and Drew Carey, MD, discuss recurrence of papilledema after discontinuation of GLP-1 receptor agonists and the implications for monitoring patients with idiopathic intracranial hypertension
2017: The FDA approves a long-acting, once weekly GLP-1 RA injectable exenatide (Bydureon BCise)
Evaluation may include detailed lab testing, body composition analysis, and a full review of lifestyle and medical history
Sometimes years before it's available everywhere
Researching an off-ramp Clinicians have a body of research on starting GLP-1s, but theres less evidence on how to stop them, Biermann says
US$ 21.67
US$ 28.96
US$ 23.39
US$ 29.94
US$ 25.58
US$ 23.20
US$ 21.13
